This project aims to increase public trust in genomic technologies used to diagnose and prevent mitochondrial disease by developing a best practice framework for their use and implementation in Australia. It will provide a comprehensive analysis of the ethical, legal and social issues that arise in this domain, foster understanding of mitochondrial disease and genomics in the medical and wider Australian community, and present a comprehensive view of current practice in reproductive genomics for mitochondrial disease. The best practice framework it develops will guide clinical practice and shape policy and regulation of the provision of reproductive genomics for mitochondrial disease.
|Effective start/end date||1/07/20 → 30/06/22|
- Department of Health (Australia): AUD499,417.00